Jobs with Genentech & Company Information

Search for jobs at Genentech

Genentech Company History

Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are licensed to market products based on the Company’s technology. Genentech commercializes various products in the United States, including Avastin, Rituxan, Herceptin, Lucentis, Xolair, Tarceva, Nutropin, Activase, TNKase, Cathflo Activase, Pulmozyme and Raptiva. The Company’s licensed products include Trastuzumab, Rituximab, Bevacizumab, Dornase alfa, recombinant, Alteplase and Tenecteplase, Somatropin, Daclizumab, Ranibizumab, Etanercept, Adalimumab and Infliximab. In March 2009, Roche Holding Ltd. completed the acquisition of Genentech.

Genentech ZoomInfo Information

Industries

• Healthcare
• Pharmaceuticals
• Biotechnology
• Drug Manufacturing & Research

Key Personnel

• Arthur Levinson - Chairman and Chief Executive Officer
• Steve Krognes - Finance and Information Technology and Chief Financial Officer
• Robert Andreatta - Vice President, Controller and Chief Accounting Officer
• Richard Scheller - Executive Vice President, Research and Chief Scientific Officer
• Todd Pierce - Chief Information Officer
• Charles Calderaro - Vice President and General Manager, Vacaville Product Operations
• Hal Barron - Executive Vice President, Global Development and Chief Medical Officer
• Jim Miller - Vice President and General Manager, Singapore Product Operations
• Larry Sanders - Vice President and General Manager, Oceanside Product Operations
• Varun Nanda - Senior Vice President, Global Head, Oncology Product Strategy

Genentech Financial News

• Yahoo! Finance: DNA News

Work for Genentech and want to make adjustments to this page? Contact us to be given access to our management tools.